Immune Checkpoint Inhibitors May Be Associated with High Activity in MSI-H Cancers

Patients with pretreated microsatellite instability-high cancers treated with immune checkpoint inhibitors were found to have high activity, independent of tumor type and drug used.

Source: CancerNetwork - May 23, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news